PL3345899T3 - Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin - Google Patents
Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokinInfo
- Publication number
- PL3345899T3 PL3345899T3 PL18156011T PL18156011T PL3345899T3 PL 3345899 T3 PL3345899 T3 PL 3345899T3 PL 18156011 T PL18156011 T PL 18156011T PL 18156011 T PL18156011 T PL 18156011T PL 3345899 T3 PL3345899 T3 PL 3345899T3
- Authority
- PL
- Poland
- Prior art keywords
- benzofuran
- chemokine receptor
- receptor modulators
- sulfonamide derivatives
- sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261605300P | 2012-03-01 | 2012-03-01 | |
PCT/US2013/028607 WO2013130962A1 (en) | 2012-03-01 | 2013-03-01 | Benzofuran- 2 - sulfonamide derivatives as chemokine receptor modulators |
EP13711995.4A EP2820010B1 (en) | 2012-03-01 | 2013-03-01 | Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators |
EP18156011.1A EP3345899B1 (en) | 2012-03-01 | 2013-03-01 | Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3345899T3 true PL3345899T3 (pl) | 2020-07-27 |
Family
ID=47902352
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL18156011T PL3345899T3 (pl) | 2012-03-01 | 2013-03-01 | Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin |
PL13711995T PL2820010T3 (pl) | 2012-03-01 | 2013-03-01 | Pochodne benzofurano-2-sulfonamidu jako modulatory receptora chemokinowego |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13711995T PL2820010T3 (pl) | 2012-03-01 | 2013-03-01 | Pochodne benzofurano-2-sulfonamidu jako modulatory receptora chemokinowego |
Country Status (12)
Country | Link |
---|---|
US (4) | US8927544B2 (pl) |
EP (2) | EP3345899B1 (pl) |
AU (2) | AU2013225815B2 (pl) |
CA (1) | CA2866078C (pl) |
CY (1) | CY1120528T1 (pl) |
DK (2) | DK3345899T3 (pl) |
ES (2) | ES2791534T3 (pl) |
HU (2) | HUE038700T2 (pl) |
PL (2) | PL3345899T3 (pl) |
PT (2) | PT3345899T (pl) |
SI (1) | SI2820010T1 (pl) |
WO (2) | WO2013130958A1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT3345899T (pt) * | 2012-03-01 | 2020-05-20 | Allergan Inc | Derivados de benzofurano-2-sulfonamida como moduladores dos receptores de quimioquinas |
ES2708563T3 (es) | 2013-03-12 | 2019-04-10 | Allergan Inc | Derivados de sulfonamida como moduladores de receptores de quimiocinas |
AR098583A1 (es) * | 2013-12-02 | 2016-06-01 | Allergan Inc | Compuesto de sulfonamida de benzotiofeno, composición farmacéutica que lo comprende y su uso para la preparación de dicha composición |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1507756B1 (en) | 2002-05-24 | 2015-07-22 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
EP1643960A2 (en) | 2003-07-02 | 2006-04-12 | Merck & Co., Inc. | Arylsulfonamide derivatives |
AU2004265312B2 (en) * | 2003-08-08 | 2010-05-20 | Janssen Pharmaceutica, N.V. | Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
US7622583B2 (en) * | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
US7931909B2 (en) | 2005-05-10 | 2011-04-26 | Allergan, Inc. | Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates |
GB0524786D0 (en) | 2005-12-05 | 2006-01-11 | Glaxo Group Ltd | Compounds |
US8519135B2 (en) | 2006-07-14 | 2013-08-27 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2/CCR9 |
WO2008008374A2 (en) | 2006-07-14 | 2008-01-17 | Chemocentryx, Inc. | Ccr2 inhibitors and methods of use thereof |
NZ574759A (en) * | 2006-07-14 | 2010-10-29 | Chemocentryx Inc | Triazolyl phenyl benzenesulfonamides |
US7884110B2 (en) | 2007-07-12 | 2011-02-08 | Chemocentryx, Inc. | Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation |
TWI440638B (zh) | 2007-10-30 | 2014-06-11 | Otsuka Pharma Co Ltd | 雜環化合物及其藥學組成物 |
EP2955173B1 (en) * | 2010-12-16 | 2017-10-04 | Allergan, Inc. | 1,2-bis-sulfonamide derivatives as chemokine receptor modulators |
CN106220618B (zh) * | 2010-12-16 | 2019-04-26 | 阿勒根公司 | 作为趋化因子受体调节剂的硫衍生物 |
US8524745B2 (en) * | 2011-12-12 | 2013-09-03 | Allergan, Inc. | Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators |
PT3345899T (pt) * | 2012-03-01 | 2020-05-20 | Allergan Inc | Derivados de benzofurano-2-sulfonamida como moduladores dos receptores de quimioquinas |
ES2708563T3 (es) * | 2013-03-12 | 2019-04-10 | Allergan Inc | Derivados de sulfonamida como moduladores de receptores de quimiocinas |
-
2013
- 2013-03-01 PT PT181560111T patent/PT3345899T/pt unknown
- 2013-03-01 PT PT13711995T patent/PT2820010T/pt unknown
- 2013-03-01 ES ES18156011T patent/ES2791534T3/es active Active
- 2013-03-01 WO PCT/US2013/028599 patent/WO2013130958A1/en active Application Filing
- 2013-03-01 PL PL18156011T patent/PL3345899T3/pl unknown
- 2013-03-01 WO PCT/US2013/028607 patent/WO2013130962A1/en active Application Filing
- 2013-03-01 HU HUE13711995A patent/HUE038700T2/hu unknown
- 2013-03-01 US US13/782,159 patent/US8927544B2/en active Active
- 2013-03-01 DK DK18156011.1T patent/DK3345899T3/da active
- 2013-03-01 PL PL13711995T patent/PL2820010T3/pl unknown
- 2013-03-01 DK DK13711995.4T patent/DK2820010T3/en active
- 2013-03-01 EP EP18156011.1A patent/EP3345899B1/en active Active
- 2013-03-01 CA CA2866078A patent/CA2866078C/en active Active
- 2013-03-01 SI SI201331119T patent/SI2820010T1/sl unknown
- 2013-03-01 HU HUE18156011A patent/HUE049728T2/hu unknown
- 2013-03-01 ES ES13711995.4T patent/ES2683046T3/es active Active
- 2013-03-01 AU AU2013225815A patent/AU2013225815B2/en active Active
- 2013-03-01 EP EP13711995.4A patent/EP2820010B1/en active Active
- 2013-03-01 US US13/782,174 patent/US8815915B2/en active Active
-
2014
- 2014-07-17 US US14/334,145 patent/US9416120B2/en active Active
-
2015
- 2015-01-05 US US14/589,681 patent/US9550746B2/en active Active
-
2018
- 2018-01-11 AU AU2018200226A patent/AU2018200226B2/en active Active
- 2018-08-07 CY CY20181100816T patent/CY1120528T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
SI2820010T1 (sl) | 2018-11-30 |
US20130231338A1 (en) | 2013-09-05 |
CA2866078C (en) | 2018-01-02 |
CA2866078A1 (en) | 2013-09-06 |
US20140329813A1 (en) | 2014-11-06 |
ES2791534T3 (es) | 2020-11-04 |
EP2820010A1 (en) | 2015-01-07 |
AU2018200226B2 (en) | 2019-09-19 |
US8927544B2 (en) | 2015-01-06 |
WO2013130958A1 (en) | 2013-09-06 |
AU2013225815A1 (en) | 2014-09-25 |
WO2013130962A1 (en) | 2013-09-06 |
PT3345899T (pt) | 2020-05-20 |
US9416120B2 (en) | 2016-08-16 |
HUE038700T2 (hu) | 2018-11-28 |
US9550746B2 (en) | 2017-01-24 |
EP2820010B1 (en) | 2018-05-09 |
US20130231339A1 (en) | 2013-09-05 |
EP3345899B1 (en) | 2020-02-19 |
AU2013225815B2 (en) | 2017-10-12 |
AU2018200226A1 (en) | 2018-01-25 |
HUE049728T2 (hu) | 2020-10-28 |
PL2820010T3 (pl) | 2018-11-30 |
EP3345899A1 (en) | 2018-07-11 |
US8815915B2 (en) | 2014-08-26 |
US20150218119A1 (en) | 2015-08-06 |
DK2820010T3 (en) | 2018-08-06 |
CY1120528T1 (el) | 2019-07-10 |
DK3345899T3 (da) | 2020-05-11 |
ES2683046T3 (es) | 2018-09-24 |
PT2820010T (pt) | 2018-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1232219A1 (zh) | 作為趨化因子受體調節劑的硫衍生物 | |
IL237212A0 (en) | Amide derivatives of benzoimidazole carboxylic acid as apj receptor modulators | |
GB201213700D0 (en) | Receptor antagnists II | |
IL251897A0 (en) | X-receptor modulators of the liver | |
HK1206333A1 (en) | Liver receptor modulators | |
HK1208867A1 (en) | Indolecarbonitriles as selective androgen receptor modulators | |
HK1209744A1 (en) | Novel selective androgen receptor modulators | |
IL235557B (en) | Modulators of 17 gpr receptors | |
HK1211025A1 (en) | Indolines | |
GB201217285D0 (en) | Indole derivatives | |
SI2820010T1 (sl) | Derivati benzofuran-2-sulfonamida kot modulatorji kemokinskih receptorjev | |
GB201223053D0 (en) | Receptor | |
AU2012904244A0 (en) | Neurotrophin-tyrosine kinase receptor signaling |